Epidermal Growth Factor Receptor Regulates Beclin-1 in Hyperoxic Acute Lung Injury

Area of Science:

• Pulmonary Medicine
• Cellular Biology
• Molecular Mechanisms of Disease

Background:

• High oxygen levels (hyperoxia) cause mortality in intensive care units (ICUs).
• Hyperoxia-induced acute lung injury (HALI) involves cell death and oxidant damage.
• The role of Beclin-1 (BCN1) in HALI pathogenesis is not fully understood.

Purpose of the Study:

• To investigate the in vivo effects of HALI on Beclin-1 (BCN1) and autophagy.
• To determine if epidermal growth factor receptor (EGFR) regulates BCN1 and autophagy in HALI.
• To explore the therapeutic potential of the EGFR-BCN1-autophagy pathway in HALI.

Main Methods:

• Examined BCN1 and autophagy markers in wildtype mice exposed to HALI using Western blot, RT-qPCR, and immunohistochemistry.
• Assessed LDH release and autophagy markers in human alveolar type-II cells (AT2s^iPSC) under HALI conditions.
• Analyzed BCN1 and autophagy in EGFR^Wa5/+ mice (reduced EGFR activity) and wildtype mice during HALI.
• Investigated the effect of a PI3K inhibitor (wortmannin) on HALI mortality.

Main Results:

• HALI increased BCN1 expression in wildtype mouse lungs and alveolar epithelium.
• HALI reduced autophagic flux, indicated by decreased LC3B-II/-I ratios in lungs and AT2s^iPSC.
• EGFR^Wa5/+ mice exhibited increased BCN1 and reduced autophagic flux during HALI compared to wildtype.
• Inhibition of autophagy via wortmannin exacerbated HALI mortality in wildtype mice.

Conclusions:

• EGFR signaling plays a protective role in HALI by regulating BCN1 and autophagy.
• The EGFR-BCN1-autophagy axis represents a novel pathway in HALI.
• This pathway holds potential for developing new therapeutic strategies for acute lung injury.